Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Problematic recreational drug use: is there a role for outpatient sexual health clinics in identifying those not already engaged with treatment services?

Caitlyn Lovett A B , T. Yamamoto A , Laura Hunter B , John White C , Paul I. Dargan A D and David M. Wood A D E
+ Author Affiliations
- Author Affiliations

A Clinical Toxicology, Guy’s and St Thomas’ National Health Service (NHS) Foundation Trust and King’s Health Partners, Westminster Bridge Road, London, SE1 7EH, UK.

B Emergency Medicine, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, Westminster Bridge Road, London, SE1 7EH, UK.

C Genitourinary Medicine, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, Westminster Bridge Road, London, SE1 7EH, UK.

D King’s College London Strand, London, WC2R 2LS, UK.

E Corresponding author. Email: David.Wood@gstt.nhs.uk

Sexual Health 12(6) 501-505 https://doi.org/10.1071/SH15052
Submitted: 8 February 2015  Accepted: 6 July 2015   Published: 5 October 2015

Abstract

Background: There is an association between recreational drug use, high-risk sexual activity and sexually transmissible infections. Studies have shown a higher prevalence of drug use in those accessing sexual health services; however, there are minimal data on the proportion with problematic recreational drug use. We aimed to understand whether sexual health clinics could identify problematic drug and alcohol use as a novel referral pathway into treatment services. Methods: Males attending two sexual health clinics in London completed questionnaires. Data were collected on demographics; gender of sexual partner; use of alcohol and recreational drugs; if they felt they had problematic use of drugs, alcohol or both; and if they had sought help for their problematic use. Results: In total, 867 males completed the questionnaire; 387 (44.7%) were men who have sex with men (MSM). MSM had significantly higher lifetime use of any drug compared with non-MSM (80.6% vs. 62.5%; P < 0.0001). Thirty-five (4.7%) self-identified problematic drug or alcohol use, with no difference between MSM and non-MSM (6.3% vs. 3.5%; P = 0.08). Of those with problematic drug or alcohol use, 20 were currently or had been engaged with a treatment service and 15 had never engaged with treatment services. MSM were more likely to have ever sought help for drug or alcohol problems compared with non-MSM (P = 0.003). Conclusions: Some individuals attending sexual health clinics with problematic drug use have not engaged with treatment services. It is therefore appropriate to develop screening tools for sexual health clinics to identify these individuals and novel referral pathways to engage them in treatment services.

Additional keywords: HIV, sexual risk, sexually transmissible infection, United Kingdom.


References

[1]  UK Government Home Office. Drug misuse: findings from the 2013/14 Crime Survey for England and Wales. London: UK Government Home Office; 2014. Available online at: www.gov.uk/government/publications/drug-misuse-findings-from-the-2013-to-2014-csew/drug-misuse-findings-from-the-201314-crime-survey-for-england-and-wales [verified July2015].

[2]  Winstock A. MixMag/Global Drugs Survey 2014. MixMag 2014; 276 86–9.

[3]  Measham F, Wood DM, Dargan PI. The rise of legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs. J Subst Use 2011; 16 263–72.
The rise of legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs.Crossref | GoogleScholarGoogle Scholar |

[4]  Wood DM, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. Q J Med 2012; 105 959–64.
Limited use of novel psychoactive substances in South London nightclubs.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC38jjs1Wnsg%3D%3D&md5=1dad73f252d474d8d323101df7229bebCAS |

[5]  Guasp A. Gay and bisexual men’s health survey. London: Stonewall; 2012. Available online at: http://www.healthylives.stonewall.org.uk/lgb-health/gay-and-bisexual-men/default.aspx#main [verified July 2015].

[6]  Pantalone DW, Bimbi DS, Holder CA, Golub SA, Parsons JT. Consistency and change in club drug use by sexual minority in New York City 2002 to 2007. Am J Public Health 2010; 100 1892–5.
Consistency and change in club drug use by sexual minority in New York City 2002 to 2007.Crossref | GoogleScholarGoogle Scholar | 20724693PubMed |

[7]  Halkitis PN, Palamar JJ, Mukherjee . Poly-club-drug use among gay & bisexual men: a longitudinal analysis. Drug Alcohol Depend 2007; 89 153–60.
Poly-club-drug use among gay & bisexual men: a longitudinal analysis.Crossref | GoogleScholarGoogle Scholar | 17267140PubMed |

[8]  Hunter LJ, Dargan PI, Benzie A, White JA, Wood DM. Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgrad Med J 2014; 90 133–8.
Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2czhvFalug%3D%3D&md5=84768e3db75ffa99d82dc5d86e15d1e9CAS | 24390619PubMed |

[9]  European Centre for Disease Control and Prevention (ECDCP). The European Men-Who-Have-Sex-With-Men Internet survey: findings from 38 countries. Stockholm: ECDCP; 2013. Available online at: http://www.emis-project.eu/sites/default/files/public/publications/emis-2010_european_msm_internet_survey_38_countries_v4.pdf [verified July 2015].

[10]  Bourne A, Reid D, Hickson F, Torres Rueda S, Weatherburn P. The Chemsex Study? Drug use in sexual settings among gay and bisexual men in Lambeth, Southwark and Lewisham. London: Sigma Research, London School of Hygiene and Tropical Medicine. Available from: http://www.sigmaresearch.org.uk/files/report2014a.pdf [verified July 2015].

[11]  Purcell DW, Moss S, Remien RH, Woods WJ, Parsons JT. Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners. AIDS 2005; 19 S37–47.
Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners.Crossref | GoogleScholarGoogle Scholar | 15838193PubMed |

[12]  Colfax G, Vittinghoff E, Husnik MJ, McKirnan D, Buchbinder S, Koblin B, Celum C, Chesney M, Huang Y, Mayer K, Bozeman S, Judson FN, Bryant KJ, Coates TJ, The EXPLORE Study Team Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 2004; 159 1002–12.
Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 15128613PubMed |

[13]  Benotsch EG, Lance SP, Nettles CD, Koester S. Attitudes toward methamphetamine use and HIV risk behavior in men who have sex with men. Am J Addict 2012; 21 S35–42.
| 23786508PubMed |

[14]  Lea T, Mao L, Bath N, Prestage G, Zablotska I, de Wit J, Holt M. Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection. AIDS Behav 2013; 17 1344–51.
Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection.Crossref | GoogleScholarGoogle Scholar | 23321949PubMed |

[15]  Forrest DW, Metsch LR, Lalota M, Cardenas G, Beck DW, Jeanty Y. Crystal methamphetamine use and sexual risk behaviours among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health 2010; 87 480–5.
Crystal methamphetamine use and sexual risk behaviours among HIV-positive and HIV-negative men who have sex with men in South Florida.Crossref | GoogleScholarGoogle Scholar | 20101468PubMed |

[16]  Mitcheson L, McCambridge J, Byrne A, Hunt N, Winstock A. Sexual health risk among dance drug users: a cross sectional comparison with nationally representative data. Int J Drug Policy 2008; 19 304–10.
Sexual health risk among dance drug users: a cross sectional comparison with nationally representative data.Crossref | GoogleScholarGoogle Scholar | 18638703PubMed |

[17]  National AIDS Trust (NAT). HIV and injecting drug use. London: NAT; 2013. Available online at: http://www.nat.org.uk/media/Files/Policy/2013/HIV_and_Injecting_Drug_Use_Report_2013.pdf [verified July 2015].

[18]  Kirby T, Thornber-Dunwell M. High-risk drug practices tighten grip of London gay scene. Lancet 2013; 381 101–2.
High-risk drug practices tighten grip of London gay scene.Crossref | GoogleScholarGoogle Scholar | 23320280PubMed |

[19]  Kirby T, Thornber-Dunwell M. New HIV diagnoses in London’s gay men continue to soar. Lancet 2013; 382 295
New HIV diagnoses in London’s gay men continue to soar.Crossref | GoogleScholarGoogle Scholar | 23901409PubMed |

[20]  Cook RL, Comer DM, Wiesenfeld HC, Chang C-CH, Tarter R, Lave JR, Clark DB. Alcohol and drug use and related disorders: an underrecognised health issue among adolescents and young adults attending sexually transmitted disease clinics. Sex Transm Dis 2006; 33 565–70.
Alcohol and drug use and related disorders: an underrecognised health issue among adolescents and young adults attending sexually transmitted disease clinics.Crossref | GoogleScholarGoogle Scholar | 16572042PubMed |

[21]  Public Health England (PHE). Sexually transmitted infections and chlamydia screening in England in 2013. London: PHE; 2015. Available online at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/345181/Volume_8_number_24_hpr2414_AA_stis.pdf [verified July 2015].

[22]  Wood DM, Measham F, Dargan PI. ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night time economy one year after control. J Subst Use 2012; 68 853–6.
| 1:CAS:528:DC%2BC38XmtFaqsbw%3D&md5=a0179dd8d0cc8463325eda73da0892f5CAS |

[23]  Rooney E. All partied out? Substance use in Northern Ireland’s LGB&T community. Belfast, The Rainbow Project; 2012. Available online at: http://www.rainbow-project.org/assets/publications/All%20Partied%20Out.pdf [verified July 2015].

[24]  Drug survey 2014. Gay Times 2014; 436 68–75. Anon

[25]  McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult psychiatric morbidity in England, 2007: results of a household survey. London: National Health Services; 2009. Available online at: http://www.hscic.gov.uk/catalogue/PUB02931/adul-psyc-morb-res-hou-sur-eng-2007-rep.pdf [verified July 2015].

[26]  Moore K, Dargan PI, Wood DM, Measham F. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. Eur Addict Res 2013; 19 276–82.
Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine.Crossref | GoogleScholarGoogle Scholar | 23615495PubMed |

[27]  Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, Clarke S, Ramsey J, Holt DW, Dargan PI. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). Q J Med 2008; 101 23–9.
Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1c%2Flt1yktw%3D%3D&md5=986b7e9db6427554cf55453e1a21d0ebCAS |